Proliferative vitreoretinopathy: current and emerging treatments

References

• [No authors listed]The classification of retinal detachment with proliferative vitreoretinopathyOphthalmology19839021211256856248
   PubMed Web of Science ®Google Scholar
• PastorJCProliferative vitreoretinopathy: an overviewSurv Ophthalmol19984313189716190
   PubMed Web of Science ®Google Scholar
• WilkinsRBKulwinDRWendellLHughes Lecture. Wound healingOphthalmology1979864507510537755
   PubMed Web of Science ®Google Scholar
• VinoresSACampochiaroPAConwayBPUltrastructural and electron-immunocytochemical characterization of cells in epiretinal membranesInvest Ophthalmol Vis Sci199031114281688833
   PubMed Web of Science ®Google Scholar
• WiedemannPGrowth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degenerationSurv Ophthalmol19923653733841566240
   PubMed Web of Science ®Google Scholar
• HeriotWJMachemerRPigment epithelial repairGraefes Arch Clin Exp Ophthalmol19922301911001547975
   PubMed Web of Science ®Google Scholar
• AndersonDHSternWHFisherSKEricksonPABorgulaGAThe onset of pigment epithelial proliferation after retinal detachmentInvest Ophthalmol Vis Sci1981211 Pt 110167251293
   PubMed Web of Science ®Google Scholar
• Mueller-JensenKMachemerRAzarniaRAutotransplantation of retinal pigment epithelium in intravitreal diffusion chamberAm J Ophthalmol1975803 Pt 25305371163601
   PubMed Web of Science ®Google Scholar
• CampochiaroPABryanJA3rdConwayBPJaccomaEHIntravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdownArch Ophthalmol198610411168516873778289
   PubMedGoogle Scholar
• EricksonPAFisherSKAndersonDHSternWHBorgulaGARetinal detachment in the cat: the outer nuclear and outer plexiform layersInvest Ophthalmol Vis Sci19832479279426862796
   PubMed Web of Science ®Google Scholar
• CookBLewisGPFisherSKAdlerRApoptotic photoreceptor degeneration in experimental retinal detachmentInvest Ophthalmol Vis Sci19953669909967730033
   PubMed Web of Science ®Google Scholar
• LeiHRheaumeMAKazlauskasARecent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathyExp Eye Res201090337638119931527
   PubMed Web of Science ®Google Scholar
• HeldinCHWestermarkBPlatelet-derived growth factor: mechanism of action and possible in vivo functionCell Regul1990185555661964089
   PubMedGoogle Scholar
• CuiJLeiHSamadAPDGF receptors are activated in human epiretinal membranesExp Eye Res200988343844419032953
   PubMed Web of Science ®Google Scholar
• LeiHHovlandPVelezGA potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathyInvest Ophthalmol Vis Sci20074852335234217460299
   PubMed Web of Science ®Google Scholar
• YamadaHYamadaEAndoAPlatelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathyAm J Pathol2000156247748710666377
   PubMed Web of Science ®Google Scholar
• MoriKGehlbachPAndoARetina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathyInvest Ophthalmol Vis Sci20024362001200612037011
   PubMed Web of Science ®Google Scholar
• IkunoYLeongFLKazlauskasAAttenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptorInvest Ophthalmol Vis Sci200041103107311610967071
   PubMed Web of Science ®Google Scholar
• CampochiaroPAHackettSFVinoresSAPlatelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cellsJ Cell Sci1994107Pt 9245924697844163
   PubMed Web of Science ®Google Scholar
• IkunoYKazlauskasAAn in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptorInvest Ophthalmol Vis Sci20024372406241112091444
   PubMed Web of Science ®Google Scholar
• ZhengYIkunoYOhjMPlatelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathyJpn J Ophthalmol200347215816512738549
   PubMed Web of Science ®Google Scholar
• LeiHVelezGHovlandPHiroseTGilbertsonDKazlauskasAGrowth factors outside the PDGF family drive experimental PVRInvest Ophthalmol Vis Sci20095073394340319324843
   PubMed Web of Science ®Google Scholar
• LeiHKazlauskasAGrowth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cellsJ Biol Chem2009284106329633619126548
   PubMed Web of Science ®Google Scholar
• PennockSKazlauskasAVascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responsesMol Cell Biol201232101955196622431518
   PubMed Web of Science ®Google Scholar
• CassidyLBarryPShawCDuffyJKennedySPlatelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disordersBr J Ophthalmol19988221811859613386
   PubMed Web of Science ®Google Scholar
• TaniharaHYoshidaMMatsumotoMYoshimuraNIdentification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cellsInvest Ophthalmol Vis Sci19933424134198440596
   PubMed Web of Science ®Google Scholar
• PfefferBAFlandersKCGuerinCJDanielpourDAndersonDHTransforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eyeExp Eye Res19945933233337821377
   PubMed Web of Science ®Google Scholar
• YokoyamaKKimotoKItohYThe PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cellsGraefes Arch Clin Exp Ophthalmol20122501152321858467
   PubMed Web of Science ®Google Scholar
• KimotoKNakatsukaKMatsuoNYoshiokaHp38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19Invest Ophthalmol Vis Sci20044572431243715223827
   PubMed Web of Science ®Google Scholar
• CarringtonLMcLeodDBoultonMIL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contractionInvest Ophthalmol Vis Sci20004151210121610752962
   PubMed Web of Science ®Google Scholar
• ConnorTBJrRobertsABSpornMBCorrelation of fibrosis and transforming growth factor-beta type 2 levels in the eyeJ Clin Invest1989835166116662708527
   PubMed Web of Science ®Google Scholar
• KonCHOcclestonNLAylwardGWKhawPTExpression of vitreous cytokines in proliferative vitreoretinopathy: a prospective studyInvest Ophthalmol Vis Sci199940370571210067974
   PubMed Web of Science ®Google Scholar
• NassarKLukeJLukeMThe novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)Graefes Arch Clin Exp Ophthalmol2011249111649166021735240
   PubMed Web of Science ®Google Scholar
• KitaTMolecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic targetNihon Ganka Gakkai Zasshi20101141192793421141072
   PubMedGoogle Scholar
• MachemerRAabergTMFreemanHMIrvineARLeanJSMichelsRMAn updated classification of retinal detachment with proliferative vitreoretinopathyAm J Ophthalmol199111221591651867299
   PubMed Web of Science ®Google Scholar
• GirardPMimounGKarpouzasIMontefioreGClinical risk factors for proliferative vitreoretinopathy after retinal detachment surgeryRetina19941454174247899716
   PubMed Web of Science ®Google Scholar
• PastorJCde la RuaERMartinFProliferative vitreoretinopathy: risk factors and pathobiologyProg Retin Eye Res200221112714411906814
   PubMed Web of Science ®Google Scholar
• NagasakiHShinagawaKMochizukiMRisk factors for proliferative vitreoretinopathyProg Retin Eye Res199817177989537796
   PubMed Web of Science ®Google Scholar
• RickerLJKesselsAGde JagerWHendrikseFKijlstraAla HeijECPrediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profilingAm J Ophthalmol Epub April 26, 2012
   Web of Science ®Google Scholar
• YangCSKhawlyJAHainsworthDPAn intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathyArch Ophthalmol1998116169779445210
   PubMedGoogle Scholar
• BorhaniHPeymanGARahimyMHThompsonHSuppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FUInt Ophthalmol199519143498537196
   PubMed Web of Science ®Google Scholar
• MoriteraTOguraYYoshimuraNBiodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathyInvest Ophthalmol Vis Sci19923311312531301399416
   PubMed Web of Science ®Google Scholar
• HuiYNLiangHCCaiYSKirchhofBHeimannKCorticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophagesGraefes Arch Clin Exp Ophthalmol199323121091148444357
   PubMed Web of Science ®Google Scholar
• TanoYChandlerDMachemerRTreatment of intraocular proliferation with intravitreal injection of triamcinolone acetonideAm J Ophthalmol19809068108167446668
   PubMed Web of Science ®Google Scholar
• RubsamenPECousinsSWTherapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathyRetina199717144509051842
   PubMed Web of Science ®Google Scholar
• KoernerFMerzAGloorBWagnerEPostoperative retinal fibrosis – a controlled clinical study of systemic steroid therapyGraefes Arch Clin Exp Ophthalmol198221962682716761238
   PubMed Web of Science ®Google Scholar
• HuiYNHuDPrevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the diseaseGraefes Arch Clin Exp Ophthalmol1999237760160510424311
   PubMed Web of Science ®Google Scholar
• JonasJBHaylerJKPanda-JonasSIntravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathyBr J Ophthalmol20008491064106710966969
   PubMed Web of Science ®Google Scholar
• BaliEFeronEJPeperkampEVeckeneerMMulderPGvan MeursJCThe effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trialGraefes Arch Clin Exp Ophthalmol2010795796220182883
   PubMed Web of Science ®Google Scholar
• ChenWChenHHouPFokAHuYLamDSMidterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathyRetina20113161137114221317835
   PubMed Web of Science ®Google Scholar
• AsariaRHKonCHBunceCAdjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trialOphthalmology200110871179118311425671
   PubMed Web of Science ®Google Scholar
• WickhamLBunceCWongDMcGurnDCharterisDGRandomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomyOphthalmology2007114469870417398320
   PubMed Web of Science ®Google Scholar
• SundaramVBarsamAVirgiliGIntravitreal low molecular weight heparin and 5-fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgeryCochrane Database Syst Rev20107CD00642120614445
   PubMed Web of Science ®Google Scholar
• WiedemannPHilgersRDBauerPHeimannKAdjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study GroupAm J Ophthalmol199812645505599780100
   PubMed Web of Science ®Google Scholar
• KumarANainiwalSChoudharyITewariHKVermaLKRole of daunorubicin in inhibiting proliferative vitreoretinopathy after retinal detachment surgeryClin Experiment Ophthalmol200230534835112213159
   PubMed Web of Science ®Google Scholar
• LemorMde BustrosSGlaserBMLow-dose colchicine inhibits astrocyte, fibroblast, and retinal pigment epithelial cell migration and proliferationArch Ophthalmol19861048122312253741255
   PubMedGoogle Scholar
• van BockxmeerFMMartinCEThompsonDEConstableIJTaxol for the treatment of proliferative vitreoretinopathyInvest Ophthalmol Vis Sci1985268114011472862129
   PubMed Web of Science ®Google Scholar
• DanielsSACoonleyKGYoshizumiMOTaxol treatment of experimental proliferative vitreoretinopathyGraefes Arch Clin Exp Ophthalmol199022865135161979953
   PubMed Web of Science ®Google Scholar
• BermanDHGombosGMProliferative vitreoretinopathy: does oral low-dose colchicine have an inhibitory effect? A controlled study in humansOphthalmic Surg19892042682722733993
   PubMedGoogle Scholar
• CampochiaroPAHackettSFConwayBPRetinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cellsInvest Ophthalmol Vis Sci199132165721846132
   PubMed Web of Science ®Google Scholar
• FekratSde JuanEJrCampochiaroPAThe effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathyOphthalmology199510234124187891978
   PubMed Web of Science ®Google Scholar
• ChangYCHuDNWuWCEffect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathyAm J Ophthalmol2008146344044618599016
   PubMed Web of Science ®Google Scholar
• PanYTElbeinADThe formation of lipid-linked oligosaccharides in Madin-Darby canine kidney cells. Changes in oligosaccharide profiles induced by glucosamineJ Biol Chem19822576279528017061450
   PubMed Web of Science ®Google Scholar
• ChesnokovVSunCItakuraKGlucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signalingCancer Cell Int200992519744341
   PubMed Web of Science ®Google Scholar
• ChangYHHorngCTChenYHInhibitory effects of glucosamine on endotoxin-induced uveitis in Lewis ratsInvest Ophthalmol Vis Sci200849125441544918719082
   PubMed Web of Science ®Google Scholar
• ChenJTChenPLChangYHChienMWChenYHLuDWGlucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitroExp Eye Res20068351052106216822504
   PubMed Web of Science ®Google Scholar
• LiangCMTaiMCChangYHGlucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cellsMol Vis2010162559257121151603
   PubMed Web of Science ®Google Scholar
• LiangCMTaiMCChangYHGlucosamine inhibits epithelial- to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathyActa Ophthalmol2011896e505e51421457483
   PubMed Web of Science ®Google Scholar
• MandavaNBlackburnPPaulDBRibozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathyInvest Ophthalmol Vis Sci200243103338334812356843
   PubMed Web of Science ®Google Scholar
• SchiffWMHwangJCOberMDSafety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathyArch Ophthalmol200712591161116717846353
   PubMedGoogle Scholar
• KuoHKWuPCYangPMChenYHWuYCHuDNEffects of topoisomerase II inhibitors on retinal pigment epithelium and experimental proliferative vitreoretinopathyJ Ocul Pharmacol Ther20072311420017341145
   PubMed Web of Science ®Google Scholar
• TurgutBUyarFUstundagBCelikerUAkpolatNDemirTThe impact of tacrolimus on growth factors in experimental proliferative vitreoretinopathyRetina201232223224121934553
   PubMed Web of Science ®Google Scholar
• TaharaYRSakamotoTROshimaYRThe antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathyCurr Eye Res199919432332910520228
   PubMed Web of Science ®Google Scholar
• MachadoRACasellaAMMalaguidoMROguidoAPExperimental study of vitreoretinal proliferation inhibition by the use of hypericinArq Bras Oftalmol200972565065420027403
   PubMed Web of Science ®Google Scholar
• ImaiKLoewensteinAKoromaBGrebeRde JuanEJrHerbimycin A in the treatment of experimental proliferative vitreoretinopathy: toxicity and efficacy studyGraefes Arch Clin Exp Ophthalmol2000238544044710901476
   PubMed Web of Science ®Google Scholar
• EiblKHLewisGPBettsKThe effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachmentInvest Ophthalmol Vis Sci20074831305131117325177
   PubMed Web of Science ®Google Scholar
• ItoSSakamotoTTaharaYThe effect of tranilast on experimental proliferative vitreoretinopathyGraefes Arch Clin Exp Ophthalmol1999237869169610459620
   PubMed Web of Science ®Google Scholar
• OshimaYSakamotoTHisatomiTTsutsumiCUenoHIshibashiTGene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathyGene Ther20029181214122012215888
   PubMed Web of Science ®Google Scholar
• de SouzaOFSakamotoTKimuraHInhibition of experimental proliferative vitreoretinopathy in rabbits by suraminOphthalmologica199520942122168545096
   PubMed Web of Science ®Google Scholar
• YuHGChungHAntiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbitsKorean J Ophthalmol1997112981059510652
   PubMedGoogle Scholar
• LeiHVelezGCuiJN-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathyAm J Pathol2010177113214020489144
   PubMed Web of Science ®Google Scholar